vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and VisionWave Holdings, Inc. (VWAV). Click either name above to swap in a different company.

VisionWave Holdings, Inc. is the larger business by last-quarter revenue ($10.0M vs $8.1M, roughly 1.2× Arcellx, Inc.). VisionWave Holdings, Inc. runs the higher net margin — -69.4% vs -766.0%, a 696.7% gap on every dollar of revenue.

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

CoMix Wave Films, Inc. is a Japanese independent animation film studio and distribution company based in Chiyoda, Tokyo, Japan. The studio is known for its anime feature films, short films, and television commercials, particularly those made by director Makoto Shinkai. It was founded in March 2007 when it split from CoMix Wave Inc., which was initially formed in 1998 from Itochu Corporation, ASATSU, and other companies. On 15 October 2024, Toho announced that they'd acquired 45 shares or 6.0...

ACLX vs VWAV — Head-to-Head

Bigger by revenue
VWAV
VWAV
1.2× larger
VWAV
$10.0M
$8.1M
ACLX
Higher net margin
VWAV
VWAV
696.7% more per $
VWAV
-69.4%
-766.0%
ACLX

Income Statement — Q1 FY2025 vs Q1 FY2026

Metric
ACLX
ACLX
VWAV
VWAV
Revenue
$8.1M
$10.0M
Net Profit
$-62.3M
$-6.9M
Gross Margin
Operating Margin
-847.6%
-65.7%
Net Margin
-766.0%
-69.4%
Revenue YoY
-79.3%
Net Profit YoY
-765.1%
-1522.6%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
VWAV
VWAV
Q4 25
$10.0M
Q1 25
$8.1M
Q4 24
$15.3M
Q3 24
$26.0M
Q2 24
$27.4M
Q1 24
$39.3M
Q4 23
$63.1M
Q3 23
$15.0M
Net Profit
ACLX
ACLX
VWAV
VWAV
Q4 25
$-6.9M
Q1 25
$-62.3M
Q4 24
$-47.1M
Q3 24
$-25.9M
Q2 24
$-27.2M
Q1 24
$-7.2M
Q4 23
$19.8M
Q3 23
$-39.3M
Operating Margin
ACLX
ACLX
VWAV
VWAV
Q4 25
-65.7%
Q1 25
-847.6%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
Q4 23
23.8%
Q3 23
-299.9%
Net Margin
ACLX
ACLX
VWAV
VWAV
Q4 25
-69.4%
Q1 25
-766.0%
Q4 24
-308.4%
Q3 24
-99.4%
Q2 24
-99.3%
Q1 24
-18.3%
Q4 23
31.4%
Q3 23
-263.0%
EPS (diluted)
ACLX
ACLX
VWAV
VWAV
Q4 25
Q1 25
$-1.13
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14
Q4 23
$0.42
Q3 23
$-0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
VWAV
VWAV
Cash + ST InvestmentsLiquidity on hand
$543.3M
$15.7K
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$3.1M
Total Assets
$648.1M
$18.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
VWAV
VWAV
Q4 25
$15.7K
Q1 25
$543.3M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Q4 23
$702.0M
Q3 23
$439.7M
Stockholders' Equity
ACLX
ACLX
VWAV
VWAV
Q4 25
$3.1M
Q1 25
$416.9M
Q4 24
$454.8M
Q3 24
$483.0M
Q2 24
$487.2M
Q1 24
$496.6M
Q4 23
$485.4M
Q3 23
$266.1M
Total Assets
ACLX
ACLX
VWAV
VWAV
Q4 25
$18.4M
Q1 25
$648.1M
Q4 24
$711.3M
Q3 24
$764.9M
Q2 24
$734.3M
Q1 24
$779.7M
Q4 23
$825.1M
Q3 23
$614.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
VWAV
VWAV
Operating Cash FlowLast quarter
$-63.1M
$-5.4M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
VWAV
VWAV
Q4 25
$-5.4M
Q1 25
$-63.1M
Q4 24
$-46.0M
Q3 24
$30.7M
Q2 24
$-36.2M
Q1 24
$-31.9M
Q4 23
$58.2M
Q3 23
$-10.1M
Free Cash Flow
ACLX
ACLX
VWAV
VWAV
Q4 25
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
Q4 23
$53.0M
Q3 23
$-18.0M
FCF Margin
ACLX
ACLX
VWAV
VWAV
Q4 25
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Q4 23
83.9%
Q3 23
-120.5%
Capex Intensity
ACLX
ACLX
VWAV
VWAV
Q4 25
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
Q4 23
8.4%
Q3 23
53.0%
Cash Conversion
ACLX
ACLX
VWAV
VWAV
Q4 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
2.94×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons